Lab Resources July 02, 2007
Return to XIFIN home page Who we are What we do Contact Us
  July 02, 2007

In This Issue:
CMS:

NHIC:

Medi-Cal:


New Diagnosis Codes

  CMS

Transmittal 207: CR5584 (PDF).
Effective Date: October 1, 2007

Medicare Contractor Annual Update of the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM)

The following are new codes:

040.41 Infant botulism
040.42 Wound botulism
058.10 Roseola infantum, unspecified
058.11 Roseola infantum due to human herpesvirus 6
058.12 Roseola infantum due to human herpesvirus 7
058.21 Human herpesvirus 6 encephalitis
058.29 Other human herpesvirus encephalitis
058.81 Human herpesvirus 6 infection
058.82 Human herpesvirus 7 infection
058.89 Other human herpesvirus infection
079.83 Parvovirus B19
200.30 Marginal zone lymphoma, unspecified site, extranodal and solid organ sites
200.31 Marginal zone lymphoma, lymph nodes of head, face, and neck
200.32 Marginal zone lymphoma, intrathoracic lymph nodes
200.33 Marginal zone lymphoma, intraabdominal lymph nodes
200.34 Marginal zone lymphoma, lymph nodes of axilla and upper limb
200.35 Marginal zone lymphoma, lymph nodes of inguinal region and lower limb
200.36 Marginal zone lymphoma, intrapelvic lymph nodes
200.37 Marginal zone lymphoma, spleen
200.38 Marginal zone lymphoma, lymph nodes of multiple sites
200.40 Mantle cell lymphoma, unspecified site, extranodal and solid organ sites
200.41 Mantle cell lymphoma, lymph nodes of head, face, and neck
200.42 Mantle cell lymphoma, intrathoracic lymph nodes
200.43 Mantle cell lymphoma, intra-abdominal lymph nodes
200.44 Mantle cell lymphoma, lymph nodes of axilla and upper limb
200.45 Mantle cell lymphoma, lymph nodes of inguinal region and lower limb
200.46 Mantle cell lymphoma, intrapelvic lymph nodes
200.47 Mantle cell lymphoma, spleen
200.48 Mantle cell lymphoma, lymph nodes of multiple sites
200.50 Primary central nervous system lymphoma, unspecified site, extranodal and solid organ sites
200.51 Primary central nervous system lymphoma, lymph nodes of head, face, and neck
200.52 Primary central nervous system lymphoma, intrathoracic lymph nodes
200.53 Primary central nervous system lymphoma, intra-abdominal lymph nodes
200.54 Primary central nervous system lymphoma, lymph nodes of axilla and upper limb
200.55 Primary central nervous system lymphoma, lymph nodes of inguinal region and lower limb
200.56 Primary central nervous system lymphoma, intrapelvic lymph nodes
200.57 Primary central nervous system lymphoma, spleen
200.58 Primary central nervous system lymphoma, lymph nodes of multiple sites
200.60 Anaplastic large cell lymphoma, unspecified site, extranodal and solid organ sites
200.61 Anaplastic large cell lymphoma, lymph nodes of head, face, and neck
200.62 Anaplastic large cell lymphoma, intrathoracic lymph nodes
200.63 Anaplastic large cell lymphoma, intra-abdominal lymph nodes
200.64 Anaplastic large cell lymphoma, lymph nodes of axilla and upper limb
200.65 Anaplastic large cell lymphoma, lymph nodes of inguinal region and lower limb
200.66 Anaplastic large cell lymphoma, intrapelvic lymph nodes
200.67 Anaplastic large cell lymphoma, spleen
200.68 Anaplastic large cell lymphoma, lymph nodes of multiple sites
200.70 Large cell lymphoma, unspecified site, extranodal and solid organ sites
200.71 Large cell lymphoma, lymph nodes of head, face, and neck
200.72 Large cell lymphoma, intrathoracic lymph nodes
200.73 Large cell lymphoma, intra-abdominal lymph nodes
200.74 Large cell lymphoma, lymph nodes of axilla and upper limb
200.75 Large cell lymphoma, lymph nodes of inguinal region and lower limb
200.76 Large cell lymphoma, intrapelvic lymph nodes
200.77 Large cell lymphoma, spleen
200.78 Large cell lymphoma, lymph nodes of multiple sites
202.70 Peripheral T cell lymphoma, unspecified site, extranodal and solid organ sites
202.71 Peripheral T cell lymphoma, lymph nodes of head, face, and neck
202.72 Peripheral T cell lymphoma, intrathoracic lymph nodes
202.73 Peripheral T cell lymphoma, intra-abdominal lymph nodes
202.74 Peripheral T cell lymphoma, lymph nodes of axilla and upper limb
202.75 Peripheral T cell lymphoma, lymph nodes of inguinal region and lower limb
202.76 Peripheral T cell lymphoma, intrapelvic lymph nodes
202.77 Peripheral T cell lymphoma, spleen
202.78 Peripheral T cell lymphoma, lymph nodes of multiple sites
233.30 Carcinoma in situ, unspecified female genital organ
233.31 Carcinoma in situ, vagina
233.32 Carcinoma in situ, vulva
233.39 Carcinoma in situ, other female genital organ
255.41 Glucocorticoid deficiency
255.42 Mineralocorticoid deficiency
258.01 Multiple endocrine neoplasia [MEN] type I
258.02 Multiple endocrine neoplasia [MEN] type IIA
258.03 Multiple endocrine neoplasia [MEN] type IIB
284.81 Red cell aplasia (acquired) (adult) (with thymoma)
284.89 Other specified aplastic anemias
288.66 Bandemia
315.34 Speech and language developmental delay due to hearing loss
331.5Idiopathic normal pressure hydrocephalus (INPH)
359.21 Myotonic muscular dystrophy
359.22 Myotonia congenital
359.23 Myotonic chondrodystrophy
359.24 Drug induced myotonia
359.29 Other specified myotonic disorder
364.81 Floppy iris syndrome
364.89 Other disorders of iris and ciliary body
388.45 Acquired auditory processing disorder
389.05 Conductive hearing loss, unilateral
389.06 Conductive hearing loss, bilateral
389.13 Neural hearing loss, unilateral
389.17 Sensory hearing loss, unilateral
389.20 Mixed hearing loss, unspecified
389.21 Mixed hearing loss, unilateral
389.22 Mixed hearing loss, bilateral
414.2Chronic total occlusion of coronary artery
415.12 Septic pulmonary embolism
423.3Cardiac tamponade
440.4Chronic total occlusion of artery of the extremities
449Septic arterial embolism
488Influenza due to identified avian influenza virus
525.71Osseointegration failure of dental implant
525.72Post-osseointegration biological failure of dental implant
525.73Post-osseointegration mechanical failure of dental implant
525.79Other endosseous dental implant failure
569.43Anal sphincter tear (healed) (old)
624.01Vulvar intraepithelial neoplasia I [VIN I]
624.02Vulvar intraepithelial neoplasia II [VIN II]
624.09Other dystrophy of vulva
664.60Anal sphincter tear complicating delivery, not associated with third-degree perineal laceration, unspecified as to episode of care or not applicable
664.61Anal sphincter tear complicating delivery, not associated with third-degree perineal laceration, delivered, with or without mention of antepartum condition
664.64Anal sphincter tear complicating delivery, not associated with third-degree perineal laceration, postpartum condition or complication
733.45Aseptic necrosis of bone, jaw
787.20Dysphagia, unspecified
787.21Dysphagia, oral phase
787.22Dysphagia, oropharyngeal phase
787.23Dysphagia, pharyngeal phase
787.24Dysphagia, pharyngoesophageal phase
787.29Other dysphagia
789.51Malignant ascites
789.59Other ascites
999.31*Infection due to central venous catheter
999.39*Infection following other infusion, injection, transfusion, or vaccination
V12.53Personal history of sudden cardiac arrest
V12.54Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits
V13.22Personal history of cervical dysplasia
V16.52Family history of malignant neoplasm, bladder
V17.41Family history of sudden cardiac death (SCD)
V17.49Family history of other cardiovascular diseases
V18.11Family history of multiple endocrine neoplasia [MEN] syndrome
V18.19Family history of other endocrine and metabolic diseases
V25.04Counseling and instruction in natural family planning to avoid pregnancy
V26.41Procreative counseling and advice using natural family planning
V26.49Other procreative management counseling and advice
V26.81Encounter for assisted reproductive fertility procedure cycle
V26.89Other specified procreative management
V49.85Dual sensory impairment
V68.01Disability examination
V68.09Other issue of medical certificates
V72.12Encounter for hearing conservation and treatment
V73.81Special screening examination, Human papillomavirus (HPV)
V84.81Genetic susceptibility to multiple endocrine neoplasia [MEN]
V84.89Genetic susceptibility to other disease

 


Date by which Updates/Changes/Deletions Must Be Submitted to NPPES

  CMS

CMS will be disseminating provider information contained in the National Plan and Provider Enumeration System (NPPES) on August 1, 2007. Providers, assigned National Provider Identifiers (NPIs), are asked to view their NPPES data and to update, change, or delete (where permitted) the data that will be disclosed under the FOIA.

CMS makes available a document to assist providers in making updates, changes, and deletions to the FOIA-disclosable NPPES provider data. This document, “National Plan and Provider Enumeration System (NPPES) Data Elements – Data Dissemination – Information for Providers” is available on the on the NPI website at:   http://www.cms.hhs.gov/NationalProvIdentStand/Downloads/NPPES_FOIA_Data%20Elements_062007.pdf.

In order for providers’ updates, changes, and deletions to be reflected in the initial downloadable file, providers must ensure that their updates, changes, and deletions are submitted to NPPES no later than July 16, 2007. To ensure the inclusion of updates, changes, and deletions in the initial downloadable file, July 16 is the last date on which they may be submitted via the web-based process, and is the last date by which the NPI Enumerator can receive them on the paper NPI Application/Update form (CMS-10114).

 


CMS Delays Dissemination of NPPES Data

  CMS

Approximately 98% of the 2.3 million covered health care providers now have NPIs. Health plans, health care clearinghouses and health care providers are now transitioning to the implementation phase for NPI compliance.

The NPPES Data Dissemination Notice (CMS-6060-N) was published on May 30, 2007. NPPES health care provider data that are required to be disclosed under the Freedom of Information Act (FOIA) will be made publicly available. The FOIA-disclosable data will be made available in an initial file downloadable from the Internet, with monthly update files also downloadable from the Internet, and in a query-only database (the NPI Registry) whereby users can query by NPI or provider name. The Notice stated that these data will be available 30 days after the publication date, and CMS had previously stated that they would be available on June 28, 2007.

CMS believes that health care providers need additional time, beyond what was afforded in the Data Dissemination Notice, in which to view their FOIA-disclosable NPPES data and make any updates or deletions (where permitted) that they feel are necessary. Therefore, CMS has decided to delay the dissemination of FOIA-disclosable NPPES health care provider data until August 1, 2007, 60 days after the publication date of the Notice.

 


California LCD Update

  NHIC - Medicare

Flow Cytometry and Immunocytochemistry for Cancer Diagnoses and Prognoses 

Added ICD-9-CM codes 283.0, 283.9, 284.01, 284.09, 284.1-285.0, 285.8, and 285.9 per provider request. Added information regarding Anemia, Repeat Testing and Correct Coding Initiative.

Transmittal 207: NHIC, Corp. - Northern California - 31140.

Transmittal 207: NHIC, Corp. - Southern California - 31146.

 


Quarterly Certs Review

  NHIC - Medicare

NHIC and CMS continue to focus identification of provider compliance errors on duplicate claim denials. NHIC denied 4.00% of submitted claims as duplicates during the month of May 2007. Analysis indicates the following specialties as high volume duplicate submitters:

Specialty % of claim denials:

  1. Family Practice 7.08%
  2. Dermatology 5.14%
  3. Physical Therapist In Private Practice 5.00%
  4. Internal Medicine 4.84%
  5. Podiatry and/or Surgical Chiropody 3.94%
  6. Cardiology 3.91%
  7. Multiple Specialty Group 3.73%
  8. Ophthalmology 3.43%
  9. Diagnostic Radiology 3.24%
  10. Clinical Laboratory 2.21%

NHIC denied a total of $90,610,665 dollars due to duplicate claims during the month of May 2007. NHIC reminds providers that duplicate billing is not cost effective for the Medicare program.

Duplicate submissions are also the number one reason for poor provider compliance in the CERT review. Remember, duplicate billing is considered abusive and can result in additional auditing of your billing practice. Post your payments and denials to your records promptly. Review the reasons for denials and take the appropriate action. Check the IVR for payment information. Don’t automatically rebill services.

 


2007 CPT-4/HCPCS Updates

  Medi-Cal

Medi-Cal General Medicine: Bulletin 396 (PDF).
Pathology Billing Restrictions

The following CPT-4 codes must be billed with the appropriate split-bill modifiers (26, 99, TC or ZS): 82107, 83698, 83913, 86788, 86789, 87305, 87498, 87640, 87641, 87653 and 87808. Code 88314 is not reimbursable with codes 17311 – 17315 for a routine frozen section stain. However, it is separately reimbursable for a non-routine frozen section stain when it is billed with modifier 59. Codes 88302 – 88309 (surgical pathology) are not reimbursable with codes 17311 – 17315 (Mohs surgery) unless there is documentation that the pathology claims are for different specimens.

 


Medi-Cal Transitions to CMS-1500 Form and NPI

  Medi-Cal

Medi-Cal General Medicine: Bulletin 394 (PDF).
May 2007

From April 23, 2007 to June 24, 2007, Medi-Cal will accept both the HCFA 1500 and CMS-1500 form. Providers using the HCFA 1500, however, can only enter their Medi-Cal provider number. Providers may choose to fully transition to the new CMS-1500 claim form at any time during this two-month period before the use of the CMS-1500 becomes mandatory. Beginning June 25, 2007, Medi-Cal will only accept the CMS-1500.

Also, beginning May 23, 2007, the NPI, if available, should be reported along with the Medi-Cal provider number, but is not necessary for proper adjudication. The Medi-Cal provider number must be reported on all claims through November 25, 2007. Claims received with only an NPI will not be processed.

Beginning November 26, 2007, providers must use only an NPI when submitting CMS-1500 claims to Medi-Cal.

 


Nonspecific ICD-9-CM Codes Not Billable with a Lab Procedure Code

  Medi-Cal

Medi-Cal General Medicine: Bulletin 396 (PDF).

Effective for dates of service on or after July 1, 2007, the following nonspecific ICD-9-CM diagnosis codes are not billable with a laboratory procedure code: V70, V70.0, V70.5 – V70.9, V72, V72.1 and V72.9. This does not change the policy that any laboratory procedure must be billed with a diagnosis code, nor does it change the policy requiring specific diagnosis codes for certain laboratory procedures. Providers billing a laboratory procedure code with any of the above diagnosis codes will have their claims denied for nonspecific diagnosis.

Return to Top

 

Contact Us | Privacy Statement | Legal
©2007 XIFIN®, Inc. All rights reserved.